Penumbra Inc reports operating loss of USD0.9m for 2018.
M2 EQUITYBITES-February 27, 2019-Penumbra Inc reports operating loss of USD0.9m for 2018
(C)2019 M2 COMMUNICATIONS http://www.m2.com
Healthcare company Penumbra Inc (NYSE:PEN) stated on Tuesday that it recorded an operating loss of USD0.9m for the year ended 31 December 2018.
This marks a decline in earnings when compared with operating income of USD1.2m for the year ended 31 December 2017.
Total revenue of USD444.9m was collected for the year ended 31 December 2018, a rise of 33.3%, or 32.2% in constant currency over total revenue of USD333.8m for 2017, The US represented 65% of total revenue and international represented 35% of total revenue for the year ended 31 December 2018.
R&D expenses of USD36.2m were recorded for the year ended 31 December 2018, an increase versus R&D of USD31.7m for the year ended 31 December 2017.
For 2019, the company expects total revenue to be in the range of USD525m to USD535m.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Article Type:||Financial report|
|Date:||Feb 27, 2019|
|Previous Article:||Spotify announces launch of services in India.|
|Next Article:||Fluence announces commercial agreement worth EUR165m with Ivory Coast government.|